Related Experiment Video
Updated: Jul 19, 2025

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Cardiopulmonary physiological effects of diuretic therapy in preterm infants with chronic pulmonary hypertension
Faith Zhu1,2, Daniel Ibarra Rios3, Sebastien Joye4
1Department of Paediatrics, Mount Sinai Hospital, Toronto, ON, Canada.
Objective:
Using targeted neonatal echocardiography (TNE) to examine cardiopulmonary physiological impact of diuretics in preterm infants with chronic pulmonary hypertension (cPH).
Study Design:
Retrospective study comparing TNE indices pre- and ≤2 weeks (post) of initiating diuretic therapy in infants born <32 weeks gestational age with cPH.
Results:
Twenty-seven neonates with mean gestational age, birthweight and interval between pre-post diuretic TNE of 27.0 ± 2.8 weeks, 859 ± 294 grams, and 7.8 ± 3.0 days respectively were studied. Diuretics was associated with improvement in pulmonary vascular resistance [pulmonary artery acceleration time (PAAT); 34.27(9.76) vs. 40.24(11.10)ms, p = 0.01), right ventricular (RV) ejection time:PAAT ratio [5.92(1.66) vs. 4.83(1.14), p < 0.01)], RV fractional area change [41.6(9.8) vs. 46.4(6.5%), p = 0.03)] and left ventricular myocardial performance index [0.55(0.09) vs. 0.41(0.23), p < 0.01)]. Post-treatment, frequency of bidirectional/right-to-left inter-atrial shunts decreased significantly (24% vs. 4%, p = 0.05).
Conclusion:
Primary diuretic treatment in neonates with cPH may result in improvement in PVR, RV and LV function and compliance.
Related Concept Videos
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Action of Diuretics
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Cycle: Exhalation
Heart Failure VI: Adjunct Therapies
Mitral Stenosis I: Introduction

